AZGP1 antibody
Quick Overview for AZGP1 antibody (ABIN7232200)
Target
See all AZGP1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Purpose
- Rabbit Anti-ZA2G Polyclonal Antibody
-
Specificity
- The antibody detects endogenous levels of ZA2G protein
-
Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from part region of human ZA2G protein
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-2000,ELISA 1:5000-20000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS, 50 % glycerol, 0.05 % Proclin 300, 0.05 %BSA
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
-
Expiry Date
- 12 months
-
-
- AZGP1 (alpha-2-Glycoprotein 1, Zinc-Binding (AZGP1))
-
Alternative Name
- ZA2G
-
Background
- Zinc-alpha-2-glycoprotein, Zn-alpha-2-GP, Zn-alpha-2-glycoproteinAZGP1 (Alpha-2-Glycoprotein 1, Zinc-Binding) is a Protein Coding gene. Diseases associated with AZGP1 include Hidrocystoma and Clear Cell Hidradenoma. Among its related pathways are Miscellaneous transport and binding events and Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds. Stimulates lipid degradation in adipocytes and causes the extensive fat losses associated with some advanced cancers. May bind polyunsaturated fatty acids.
-
Molecular Weight
- 32kD
-
Gene ID
- 563
-
UniProt
- P25311
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
Target
-